SCHEDULE 14C
(Rule 14c-101)
INFORMATION REQUIRED IN INFORMATION STATEMENT
SCHEDULE 14C INFORMATION
Information Statement Pursuant to Section 14(c)
of the Securities Exchange Act of 1934
(Amendment No.___)
Check the appropriate box:
|X| Preliminary Information Statement
|_| Confidential, for use of the Commission only (as permitted by Rule
14c-5(d)(2))
|_| Definitive Information Statement
MARKETSHARE RECOVERY, INC.
--------------------------
(Name of Registrant as Specified in its Charter)
Payment of Filing Fee (Check the appropriate box):
|_| Fee computed on table below per Exchange Act Rules 14C-5(g) and 0-11.
1. Title of each class of securities to which transaction applies:
---------------------------------------------------------------------
2. Aggregate number of securities to which transaction applies:
---------------------------------------------------------------------
3. Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11:
---------------------------------------------------------------------
4. Proposed maximum aggregate value of transaction:
---------------------------------------------------------------------
|_| Check box if any part of the fee is offset as provided by Exchange Rule
0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
1. Amount Previously Paid:
---------------------------------------------------------------------
2. Form, Schedule or Registration Statement No.:
---------------------------------------------------------------------
3. Filing Party:
---------------------------------------------------------------------
4. Date Filed:
---------------------------------------------------------------------
MARKETSHARE RECOVERY, INC.
33 SOUTH SERVICE ROAD, SUITE 111
JERICHO, NEW YORK 11753
INFORMATION STATEMENT PURSUANT TO SECTION 14(C) OF THE
SECURITIES EXCHANGE ACT OF 1934 AND REGULATION 14C THEREUNDER
------------------
WE ARE NOT ASKING YOU FOR A PROXY AND YOU
ARE REQUESTED NOT TO SEND US A PROXY
------------------
To the Stockholders of MarketShare Recovery, Inc.:
NOTICE IS HEREBY GIVEN that certain stockholders of MarketShare Recovery,
Inc., a Delaware corporation ("MarketShare" or the "Company") have consented to
taking of corporate actions by consent in lieu of a meeting of stockholders. The
corporate actions will be effective 20 days after the mailing of this
information statement to:
1. Approve an amendment to our Certificate of Incorporation which
changes the name of the Company to bioMETRX, Inc.
Only stockholders of record at the close of business on September 6, 2005
are entitled to notice of these corporate actions. Holders of 53.4% of our
Common Stock gave their written consent to the above corporate actions. This
written consent was obtained pursuant to Section 228(a) of the Delaware General
Corporation Law, as amended.
For further information regarding the matters as to which stockholder
consent was given, I urge you to carefully read the accompanying Information
Statement. If you have questions about these proposals or would like additional
copies of the Information Statement, you should contact Mark Basile, Secretary,
MarketShare Recovery, Inc., 33 South Service Road, Suite 111, Jericho, New York
11753, telephone: (516) 750-9733.
By order of the Board of Directors
Mark Basile
President and Chief Executive Officer
Jericho, New York
September ___, 2005
MARKETSHARE RECOVERY, INC.
33 SOUTH SERVICE ROAD, SUITE 111
JERICHO, NEW YORK 11753
---------------
INFORMATION STATEMENT PURSUANT TO SECTIONS 14(C) AND 14(F)
OF THE SECURITIES AND EXCHANGE ACT OF 1934
---------------
WE ARE NOT ASKING YOU FOR A PROXY
AND YOU ARE REQUESTED NOT TO SEND US A PROXY
----------------
This Information Statement (the "Information Statement") is being mailed
on or about September ___, 2005 to the holders of record at the close of
business on September 6, 2005, (the "Record Date") of the common stock, $.001
par value per share (the "Common Stock") of MarketShare Recovery, Inc. (the
"Company"), in connection with the Company's acquisition of bioMETRX
Technologies, Inc. ("bioMETRX").
This Information Statement is also being mailed to the Company's
shareholders in connection with a proposed action by written consent to
authorize and approve an amendment of the Company's Certificate of Incorporation
which changes the name of the Company to "bioMETRX, Inc."
Members of the Board of Directors and stockholders owning or having voting
authority for 9,477,147 shares of outstanding Common Stock have voted in favor
of the above action (the "Consenting Stockholders"). These stockholdings
represent approximately 53.4% of the total outstanding common stock of
MarketShare sufficient to take the proposed action on the record date of
September 6, 2005. Pursuant to Reg.ss.240.14c-2(b), this action will not be
effective until 20 days after this Information Statement is mailed to
stockholders. Dissenting stockholders do not have any statutory appraisal rights
as a result of the action taken. The Board of Directors does not intend to
solicit any proxies or consents from any other stockholders in connection with
this action.
Section 141(f) of the Delaware General Corporation Law (the "Delaware
Law") provides that any action which may be taken at any annual or special
meeting of stockholders may be taken without a meeting and without prior notice
if a consent in writing setting forth the action taken is signed by the holders
of outstanding stock having not less than the minimum number of votes that would
be necessary to take such action. In order to eliminate the costs and management
time involved in obtaining proxies and in order to effect the above actions as
early as possible in order to accomplish the purposes hereafter described, the
Board of Directors voted to utilize, and did in fact obtain, the written consent
of the Consenting Stockholders who own shares representing a majority of our
common stock.
Pursuant to Section 228(c) of the Delaware Law, we are required to provide
prompt notice of the taking of the corporate action without a meeting to the
stockholders of record who have not
2
consented in writing to such action. This Information Statement is intended to
provide such notice. No dissenters' or appraisal rights under the Delaware Law
are afforded to the Company's stockholders as a result of the approval of the
proposals.
This Information Statement is being distributed pursuant to the
requirements of Sections 14(c) and 14(f) of the Securities Exchange Act of 1934,
as amended (the "Exchange Act").
The entire cost of furnishing this Information Statement will be borne by
the Company. The Company will request brokerage houses, nominees, custodians,
fiduciaries and other like parties to forward this Information Statement to the
beneficial owners of the Common Stock held of record by them and will reimburse
such persons for their reasonable charges and expenses in connection therewith.
WHAT VOTE WAS REQUIRED TO APPROVE THE AMENDMENT
For the approval of the proposed corporate actions, the affirmative vote
of a majority of the shares of common stock outstanding and entitled to vote at
the record date, or 8,882,160 shares, was required for approval.
CONSENTING SHAREHOLDERS
On September 6, 2005, our board of directors unanimously adopted
resolutions declaring the advisability of, and recommended that shareholders
approve the amendment to the Company's Certificate of Incorporation to authorize
the change of the Corporation's name to "bioMETRX, Inc." In connection with the
adoption of these resolutions, the board elected to seek the written consent of
the holders of a majority of our outstanding shares in order to reduce the costs
and implement the proposals in a timely manner.
On September 6, 2005 the following consenting shareholders, who
collectively own 53.4% of our common stock, consented in writing to the proposed
Amendment:
Name No. of Shares Percentage
---- ------------- ----------
Mark Basile 1,953,677 11.00%
The Naples Trust 4,522,400 25.50%
Stephen Kang 1,336,644 7.50%
Russell Kuhn 1,633,334 9.22%
Clifford Zsevc 22,612 .13%
Frank Giannuzzi 8,480 .05%
--------- -----
9,477,147 53.40%
Under Delaware law, we are required to give all shareholders written
notice of any actions that are taken by written consent without a shareholder
meeting. Under Section 14(c) of the Exchange Act, the transactions cannot become
effective until 20 days after the mailing date of this Information Statement to
our shareholders.
3
We are not seeking written consent from any of our shareholders and our
other shareholders will not be given an opportunity to vote with respect to the
transactions. All necessary corporate approvals have been obtained, and this
Information Statement is furnished solely for the purposes of:
o Advising shareholders of the action taken by written consent, as
required by Delaware law; and
o Giving shareholders advance notice of the actions taken, as required
by the Exchange Act.
Shareholders who were not afforded an opportunity to consent or otherwise
vote with respect to the actions taken have no right under Delaware law to
dissent or require a vote of all our shareholders.
SECURITY OWNERSHIP OF
CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth, as of September 6, 2005, information with
respect to the securities holdings of all persons which we have reason to
believe may be deemed the beneficial owners of more than 5% of our common stock
based upon 17,764,320 shares outstanding. Also set forth in the table is the
beneficial ownership of shares of our outstanding Common Stock as of such date
of all officers and directors, individually and as a group:
Name and Address Number of Shares Percentage
---------------- ---------------- ----------
Mark Basile 7,226,077 (1)(2) 39.03%
CEO and Chairman
736 Carlisle Road
Jericho, NY 11753
The Naples Trust (3) 4,522,400 25.46%
736 Carlisle Road
Jericho, NY 11753
Stephen Kang 2,086,644 (4) 11.27%
Director Appointee
9 Herkimer Street
Jericho, NY 11750
Clifford Zsevc 22,612 *
Chief Operating Officer
10 Pinecone Lane
Westbury, NY 11590
4
Frank Giannuzzi 8,480 *
Chief Financial Officer
40 Stewart Street
Plainview, NY 11704
Russell Kuhn 1,702,324 (5) 9.55%
8680 Greenback Lane
Orangevale, CA 95662
All Officers and Directors as a Group 9,343,813 48.50%
(4 persons) (1)(2)(3)(4)
* Less than 1%.
(1) Includes 4,552,400 shares held by the Naples Trust. Mr. Basile's
mother-in-law is the trustee for the Naples Trust and Mr. Basile's wife is
the beneficiary.
(2) Includes 750,000 shares of common stock issuable within 60 days upon the
exercise of options to purchase a like number of shares.
(3) Mr. Basile's mother-in-law is the Trustee for the Naples Trust and Mr.
Basile's wife is the beneficiary.
(4) Includes 750,000 shares of common stock issuable within 60 days upon the
exercise of options to purchase a like number of shares.
(5) Includes 68,990 shares of common stock issuable within 60 days upon the
exercise of warrants to purchase a like number of shares. Excludes 275,990
shares which may be obtained upon the exercise of warrants which, by their
terms, are not exercisable within 60 days.
APPROVAL OF AMENDMENT OF THE COMPANY'S
CERTIFICATE OF INCORPORATION
Members of the Board of Directors and stockholders owning or having voting
authority for 9,477,147 shares of our outstanding common stock approved an
amendment to the Company's Certificate of Incorporation to change the name of
the Company to "bioMETRX, Inc." A copy of the amended Certificate of
Incorporation substantially in the form it will be filed with the Secretary of
the State of Delaware is attached hereto as Appendix A.
Change of Corporate Name
On May 27, 2005, we completed the merger with bioMETRX Technologies, Inc.,
a Delaware corporation pursuant to an Agreement and Plan of Merger dated April
27, 2005. In connection with the merger, the Company issued 14,218,424 shares of
its common stock to the former stockholders of bioMETRX and 182,029 warrants to
the holders of corresponding instruments of bioMETRX. Since the Company had no
meaningful operations immediately prior to the merger, the Company's current
operations is that of bioMETRX, which develops proprietary
5
biometrics-based products for the home security and electronics market.
Accordingly, the Board of Directors believes the name of the Company should
reflect its current business.
The change of corporate name will become effective upon the filing with
the Secretary of State of an amendment and restatement to the Company's
Certificate of Incorporation which states that, upon the filing of the
Certificate of Amendment the name of the Corporation will be "bioMETRX, Inc."
Approval Required
The approval of a majority of the outstanding stock entitled to vote will
be necessary to approve the proposed amendment. As discussed above, the
Company's
AVAILABLE INFORMATION
The Company is subject to the informational requirements of the Securities
Exchange Act of 1934 and, in accordance therewith, files reports and other
information with the Commission. The Registration Statement and such reports and
other information may be inspected without charge at the Public Reference Room
maintained by the Commission at Room 1024, 450 Fifth Street, N.W., Washington,
D.C. 20549, and at the Commission's Regional Office located at 500 West Madison
Street, Suite 1400, Chicago, Illinois 60661. Copies of such material may be
obtained from the Public Reference Room of the Commission at 450 Fifth Street,
N.W., Washington D.C. 20549, at prescribed rates. Information on the operation
of the Public Reference Room is available by calling the Commission at
1-800-SEC-0330. In addition, the Commission maintains an Internet site where the
Registration Statement and other information filed with the Commission may be
retrieved, and the address of such site is http://www.sec.gov. Statements made
in this Information Statement concerning the contents of any document referred
to herein are not necessarily complete.
Mark Basile
Chairman of the Board
September __, 2005
Attachments:
Appendix A - Form of Amended Certificate of Incorporation
6
STATE OF DELAWARE
CERTIFICATE OF AMENDMENT
OF
CERTIFICATE OF INCORPORATION
OF
MARKETSHARE RECOVERY, INC.
* * * * *
MarketShare Recovery, Inc., a corporation organized and existing under and
by virtue of the General Corporation Law of the State of Delaware, DOES HEREBY
CERTIFY:
FIRST: That at a meeting of the Board of Directors of MarketShare
Recovery, Inc. resolutions were duly adopted setting forth a proposed amendment
to the Certificate of Incorporation of said corporation, declaring said
amendment to be advisable and soliciting written consents of the stockholders of
said Corporation for consideration thereof. The resolution setting forth the
proposed amendment is as follows:
RESOLVED, That the Certificate of Incorporation of this corporation be
amended by changing the First Article thereof so that, as amended, said Article
shall be and read as follows:
"FIRST: Name. The name of the corporation is bioMETRX, Inc.
(hereinafter referred to as the "Corporation")."
SECOND: That thereafter, pursuant to resolution of its Board of Directors,
signed written consents were received in accordance with Section 228 of the
General Corporation Law of the State of Delaware representing the necessary
number of shares as required by statute were voted in favor of the amendment.
THIRD: That said amendment was duly adopted in accordance with the
provisions of Section 242 of the General Corporation Law of the State of
Delaware.
FOURTH: The effective date of said amendment shall be October ___, 2005.
IN WITNESS WHEREOF, said MarketShare Recovery, Inc. has caused this
certificate to be signed by Mark Basile, its President, this _____ day of
September, 2005.
MarketShare Recovery, Inc.
By:
-------------------------
Mark Basile